Retinoic acid treatment and cell aggregation independently regulate alternative splicing in P19 cells during neural differentiation

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 631-643

  Khurshid Alam, A K M ^a   Suzuki, Hitoshi ^a   Tsukahara, Toshifumi ^a  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Alternative splicing; Cell aggregation; Neural differentiation; P19 embryonic carcinoma cell; Retinoic acid

Indexed keywords

ALPHA ACTININ 1; COMPLEMENTARY DNA; ISOPROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; PROTEIN CUGBP2; RETINOIC ACID; RNA; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG; ACTININ; ACTN1 PROTEIN, MOUSE; CUGBP2 PROTEIN, MOUSE; RECEPTOR REGULATED SMAD PROTEIN; RNA BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; GENE CONSTRUCT; GENETIC TRANSFECTION; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; RNA ISOLATION; WESTERN BLOTTING; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL; TUMOR CELL LINE;

ACTININ; ALTERNATIVE SPLICING; ANIMALS; CELL AGGREGATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; MICE; NEURONS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RECEPTORS, SEROTONIN, 5-HT3; RNA; RNA-BINDING PROTEINS; SMAD PROTEINS, RECEPTOR-REGULATED; TRETINOIN;

EID: 77955060674     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090332     Document Type: Article

References (52)

1. Alam AHMK, Suzuki H, Tsukahara T. Expression analysis of Fgf8a and Fgf8b in early stage of P19 cells during neural differentiation. Cell Bio Int 2009;33:1032-7.
2. Altschul SF, Madden TM, Schaffer AA, Zhang J, Zhang Z, Miller W et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 1997;25:3389-402.
3. Bolton JA, Wood SA, Kennedy D, Don RH, Mattick JS. Retinoic aciddependent up-regulation of mouse folate receptor-α expression in embryonic stem cells, and conservation of alternative splicing patterns. Gene 1999;230:215-24.
4. Boutz PL, Stoilov P, Li Q, Lin C, Chawla G, Ostrow K et al. A posttranscriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 2007;21:1636-52.
5. Cao W, Jamison GR, Gracia-Blanco MA. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 1997;3:1456-67.
6. Coleman BA, Taylor P. Regulation of acetylcholinesterase expression during neuronal differentiation. J Biol Chem 1996;27:4410-16.
7. Coutinho-Mansfield GC, Xue Y, Zhang Y, Fu X. PTB/nPTB switch: a post-transcriptional mechanism for programming neuronal differentiation. Genes Dev 2007;21:1573-7.
8. Crowe DL, Kim R. A phosphorylation defective retinoic acid receptor mutant mimics the effects of retinoic acid on EGFR mediated AP-1 expression and cancer cell proliferation. Cancer Cell Int 2002;2:15.
9. Ding Z, Green AG, Yang X, Chernenko G, Tang S, Pater A. Retinoic acid inhibits telomerase activity and down-regulates expression but does not affect splicing of hTERT: Correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Expre Cell Res 2002;272:185-91.
10. Frade JM, Rodriquez TA. Neuroepithelial differentiation induced by ECM molecules. Methods Mol Biol 2000;139:257-64.
11. Fushimi K, Osumi N, Tsukahara T. NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs. Genes Cells 2005;10:531-41.
12. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nature Biotech 2004;22:535-46.
13. Grabowski PJ. RNA-binding proteins switch gears to drive alternative splicing in neurons. Nature Struc Mol Biol 2007;14:577-9.
14. Hamada-Kanazawa M, Ishikawa K, Nomoto K, Uozumi T, Kawai Y, Narahara M et al. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett 2004;560:192-8.
15. Hope AG, Downie DL, Sutherland L, Lambert JJ, Peters JA, Burchell B. Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. European J Pharmacol 1993;245:187-92.
16. Itoh F, Nakane T, Chiba S. Gene expression of MASH-1, MATH-1, neuroD and NSCL-2, basic helix-loop-helix proteins, during neural differentiation in P19 embryonal carcinoma cells. Tohoku J Exp Med 1997;182:327-36
17. Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, Hashimoto K et al. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J 2003;22:905-12.
18. Jones-Villeneuve EM, McBurney MW, Rogers KA, Kalnins VI. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 1982;94:253-62.
19. Jones-Villeneuve EM, Rudnicki MA, Harris JF, McBurney MW. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol 1983;3:2271-9.
20. Kanopka A, Muhlemann O, Petersen-Mahrt S, Estmer C, Ohrmalm C, Akusjarvi G. Regulation of adenovirous alternative RNA splicing by dephosphorylation of SR proteins. Nature 1998;393:185-7.
21. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptor: what are genetic studies telling us about their role in real life? Cell 1995;83:859-69.
22. Kim S, Yoon YS, Kim JW, Jung M, Kim SU, Lee YD et al. Nurogenin1 is sufficient to induce neuronal differentiation of embryonal carcinoma P19 cells in the absence of retinoic acid. Cell Mol Neurobio 2004;24:343-57.
23. Komatsu M, Kominami E, Arahata K, Tsukahara T. Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurons. Genes Cells 1999;4:593-606.
24. Krainer AR, Conway GC, Kozak D. The essential pre-mRNA splicing factor SF2 influences 59 splice site selection by activating proximal sites. Cell 1990;62:35-42.
25. Kremerskothen J, Teber I, Wendholt D, Liedtke T, Bockers TM, Bernekow A. Brain-specific splicing of a-actinin 1 mRNA. Biochem Biophy Res Commu 2002;295:678-81.
26. Matsuda M, Hyoudou T, Kadowaki M, Onuki K, Masushige S, Kida S. The administration of retinoic acid down-regulates cAMPresponsive element modulator (CREM) mRNA in vitamin A-deficient testes. Biosci Biotech Biochem 2005;69:261-6.
27. Mayeda A, Krainer AR. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992;68:365-75.
28. McBurney MW, Jones-Villeneuve EM, Edwards MK, Anderson PJ. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 1982;299:165-7.
29. McBurney MW, Rogers BJ. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev Biol 1982;98:503-8.
30. McBurney MW. P19 embryonal carcinoma cells. Int J Dev Biol 1993;37:135-40.
31. Nakakura EK, Watkins DN, Sriuranpong V, Borges MW, Nelkin BD, Ball DW. Mammalian scratch participates in neuronal differentiation in P19 embryonal carcinoma cells. Brain Res Mol Brain Res 2001;95:162-6.
32. Prasad J, Colwill L, Pawson T, Manley JL. The protein kinase CIk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Mol Cell Biol 1999;19:6991-7000.
33. Qin P, Juliet MH, Zhenping Z, Kenneth JS, Dianne R. Pre-B cell leukemia transcription factor (PBX) proteins are important mediators for retinoic acid-dependent endodermal and neuronal differentiation of mouse embryonal carcinoma P19 Cells. J Biol Chem 2004;279:16263-71.
34. Runnicki MA, McBurney MW. Cell culture methods and induction of differentiation of embryonal carcinoma cell line. In: Teratocarcomas and embryonic stem cells. IRL Press; 1987. pp. 19-49.
35. Sapkota G, Alrcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 2007;25:441-54.
36. Sasai Y, De Robertis EM. Ectodermal patterning in vertebrate embryos. Dev Biol 1997;18:5-20.
37. Sato H, Ishida S, Toda K, Matsuda R, Hayashi Y, Shigetaka M et al. New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. Curr Drug Discov Technol 2005;2:89-98.
38. Schuuring ED, van Deemter L, Roelink H, Nusse R. Transient expression of proto-oncogene int-1 during differentiation of P19 embryonal carcinoma cells. Mol Cell Biol 1989;9:1357-61.
39. Shin C, Manley JL. The SR protein represses splicing in M phase cells. Cell 2002;111:407-17.
40. Southby J, Gooding C, Smith CW. Polypyrimidine tract binding protein functions as a repressor to regulate alternative-splicing of alphaactinin mutually exclusive exons. Mol Cell Biol 1999;19:2699-711.
41. Sun Y, Wang Y, Zhang J, Tao J, Wang C, Jing N et al. ADAM23 plays multiple roles in neuronal differentiation of P19 embryonal carcinoma cells. Neurochem Res 2007;32:1217-23.
42. Suter DM, Krause KH. Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy. J Pathol 2008;215:355-68.
43. Takeyama K, Kojima R, Ohashi T, Sato T, Mano H, Masushige S et al. Retinoic acid differentially up-regulates the gene expression of retinoic acid receptor α and γ isoforms in embryo and adult rat. Biochem Biophy Res Commu 1996;222:395-400.
44. Taneja R, Rochette-Egly C, Plassat JL, Penna L, Gaub MP, Chambon P. Phosphorylation of activation functions AF-1 and AF-2 of RARα and RARγ is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 1997;16:6452-65.
45. Teramoto S, Kihara-Negishi F, Sakurai T, Yamada T, Hashimoto-Tamaoki T, Tamura S et al. Classification of neural differentiationassociated genes in P19 embryonal carcinoma cells by their expression patterns induced after cell aggregation and/or retinoic acid treatment. Oncol Reports 2005;14:1231-8.
46. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B et al. An RNA map predicting Nova-dependent splicing regulation. Nature 2006;144:580-6.
47. Waites GT, Graham IR, Jackson P, Millake BD, Patel B, Blanchard AD et al. Mutually exclusive splicing of calcium-binding domain exons in chick α-actinin. J Biol Chem 1992;267:6263-71.
48. Wang C, Xia C, Bian W, Liu L, Lin W, Chen Y et al. Cell aggregationinduced FGF8 elevation is essential for P19 cell neural differentiation. Mol Biol Cell 2006;17:3075-84.
49. Wang H, Ikeda S, Kanno S, Guang LM, Ohnishi M, Sasaki M et al. Activation of c-Jun amino-terminal kinase is required for retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells. FEBS Lett 2001;503:91-6.
50. Werner P, Kawashima E, Reid J, Hussy N, Lundstrom K, Buell G et al. Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. Mol Brain Res 1994;26:233-41.
51. Yang L, Embree LJ, Hickstein DD. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 2000;20:3345-54.
52. van der Heyden MA, Defize LH. Twenty-one years of P19 cells: What an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 2003;58:292-302.